Method of inhibiting remnant lipoprotein production

Details for Australian Patent Application No. 2008201550 (hide)

Owner Japan Tobacco Inc.

Inventors Okamoto, Hiroshi; Sasase, Tomohiko; Furukawa, Noboru

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008201550

Parent 2004275637

Filing date 4 April 2008

Wipo publication date 1 May 2008

Acceptance publication date 10 February 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/27 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/47 (2006.01) - Quinolines

Event Publications

24 April 2008 Complete Application Filed

1 May 2008 Application Open to Public Inspection

  Published as AU-B-2008201550

10 February 2011 Application Accepted

  Published as AU-B-2008201550

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201551-Methods of fabricating nanostructures and nanowires and devices fabricated therefrom

2008201549-Channel electric inductor assembly